Financials Shanghai Sanyou Medical Co., Ltd

Stocks

End-of-day quote Shanghai S.E. Other stock markets 10/06/2026			5-day change	1st Jan Change
12.41 ^CNY	-1.80%		-5.60%	-24.25%

04-27	Shanghai Sanyou Medical Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-26	Shanghai Sanyou Medical Co., Ltd announces Annual dividend, payable on June 11, 2026	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	593.4	648.9	460.7	452.6	542.8	681.5	843	1,028
Change	-	9.37%	-29.01%	-1.74%	19.92%	25.55%	23.7%	22%
EBITDA	229.9	259.7	170.6	83.35	-	-	-	-
Change	-	12.97%	-34.31%	-51.14%	-	-	-	-
EBIT ¹	202.9	228.8	117.3	14.75	51.81	113.5	171.5	238
Change	-	12.74%	-48.72%	-87.43%	251.23%	119.08%	51.1%	38.78%
Interest Paid	-	-	-	-	-	-	-	-
Earnings before Tax (EBT) ¹	217.3	240	63.8	21.66	55.2	116	174	240.5
Change	-	10.45%	-73.42%	-66.05%	154.86%	110.13%	50%	38.22%
Net income ¹	186.4	191.9	129.9	11.3	63.29	101	144.5	192.5
Change	-	2.97%	-32.31%	-91.3%	460.1%	59.58%	43.07%	33.22%
Announcement Date	21/02/22	21/02/23	23/02/24	27/02/25	26/02/26	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	21/02/22	21/02/23	23/02/24	27/02/25	26/02/26	-	-	-

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	91.29	138.2	25.79	37.44	28.38	63	65.5	68
Change	-	51.38%	-81.34%	45.19%	-24.19%	121.98%	3.97%	3.82%
Free Cash Flow (FCF) ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Announcement Date	21/02/22	21/02/23	23/02/24	27/02/25	26/02/26	-	-	-

¹CNY in Million

Estimates

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	38.74%	40.01%	37.03%	18.41%	-	-	-	-
EBIT Margin (%)	-	34.2%	35.25%	25.47%	3.26%	9.54%	16.65%	20.34%	23.14%
EBT Margin (%)	-	36.63%	36.99%	13.85%	4.79%	10.17%	17.02%	20.64%	23.38%
Net margin (%)	-	31.41%	29.57%	28.2%	2.5%	11.66%	14.82%	17.14%	18.72%
FCF margin (%)	-	-	-	-	-	-	-	-	-
FCF / Net Income (%)	-	-	-	-	-	-	-	-	-
Profitability
ROA	-	-	-	-	-	-	-	-	-
ROE	-	11.57%	10.84%	4.87%	0.59%	3.13%	4.55%	6.15%	7.6%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	15.39%	21.3%	5.6%	8.27%	5.23%	9.24%	7.77%	6.61%
CAPEX / EBITDA (%)	-	39.72%	53.22%	15.12%	44.92%	-	-	-	-
CAPEX / FCF (%)	-	-	-	-	-	-	-	-	-
Items per share
Cash flow per share ¹	-	0.4419	0.4756	0.8154	0.0334	0.1854	0.3	0.3727	0.5136
Change	-	-	7.63%	71.45%	-95.9%	454.8%	61.85%	24.24%	37.8%
Dividend per Share ¹	-	0.114	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	5.14	5.61	5.826	5.818	-	6	6.4	6.945
Change	-	-	9.13%	3.85%	-0.13%	-	-	6.67%	8.52%
EPS ¹	-	0.5698	0.5854	0.2803	0.0379	0.1727	0.2773	0.3909	0.5227
Change	-	-	2.75%	-52.12%	-86.49%	355.99%	60.53%	40.98%	33.72%
Nbr of stocks (in thousands)	-	327,959	327,959	327,959	327,959	366,809	366,809	366,809	366,809
Announcement Date	-	21/02/22	21/02/23	23/02/24	27/02/25	26/02/26	-	-	-